Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Asahi Beverages operates as a leading beverage company in Australia and New Zealand under the ownership of Japan’s Asahi Group Holdings. It produces and distributes a wide range of alcoholic beverages (notably beer) and non-alcoholic drinks including soft drinks, juices, water, energy drinks, tea-based beverages, coffee-based beverages, spirits and ready-to-drink products.
The business has grown through major acquisitions such as Schweppes Australia in 2009 and Carlton & United Breweries in 2020. It does not have clinical programs or results since it does not operate in the life sciences/biotech/pharma sector.
Its parent group also produces some food products and supplements but these are not core to the Australian/New Zealand operations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Asahi Beverages.